MX9101237A - Xantinas substituidas y procedimiento para su preparacion - Google Patents
Xantinas substituidas y procedimiento para su preparacionInfo
- Publication number
- MX9101237A MX9101237A MX9101237A MX9101237A MX9101237A MX 9101237 A MX9101237 A MX 9101237A MX 9101237 A MX9101237 A MX 9101237A MX 9101237 A MX9101237 A MX 9101237A MX 9101237 A MX9101237 A MX 9101237A
- Authority
- MX
- Mexico
- Prior art keywords
- preparation procedure
- substituted xanthines
- xanthines
- substituted
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909020959A GB9020959D0 (en) | 1990-09-26 | 1990-09-26 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9101237A true MX9101237A (es) | 1992-05-04 |
Family
ID=10682788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9101237A MX9101237A (es) | 1990-09-26 | 1991-09-24 | Xantinas substituidas y procedimiento para su preparacion |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0550570A1 (es) |
JP (1) | JPH06501251A (es) |
KR (1) | KR930702351A (es) |
AU (1) | AU653364B2 (es) |
CA (1) | CA2092430A1 (es) |
GB (1) | GB9020959D0 (es) |
IE (1) | IE913350A1 (es) |
MX (1) | MX9101237A (es) |
NZ (1) | NZ239921A (es) |
PT (1) | PT99062A (es) |
WO (1) | WO1992005175A1 (es) |
ZA (1) | ZA917610B (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR930703319A (ko) * | 1990-12-21 | 1993-11-29 | 데이빗 로버츠 | 키산틴 유도체 |
GB9210839D0 (en) * | 1992-05-21 | 1992-07-08 | Smithkline Beecham Plc | Novel compounds |
US5817662A (en) * | 1992-11-09 | 1998-10-06 | Cell Therapeutics, Inc. | Substituted amino alkyl compounds |
US5646156A (en) * | 1994-04-25 | 1997-07-08 | Merck & Co., Inc. | Inhibition of eosinophil activation through A3 adenosine receptor antagonism |
CA2206287C (en) * | 1994-12-13 | 2001-03-20 | Mark Chasin | Aryl thioxanthines |
US5821366A (en) * | 1995-05-19 | 1998-10-13 | Chiroscience Limited | Xanthines and their therapeutic use |
DZ2629A1 (fr) * | 1997-10-23 | 2003-03-08 | Smithkline Beecham Corp | Formes polymorphes nouvelles de cipamfylline procédé pour leur préparation et compositions les contenant. |
AU6895801A (en) | 2000-07-04 | 2002-01-14 | Novo Nordisk As | Heterocyclic compounds, which are inhibitors of the enzyme dpp-iv |
KR20030014394A (ko) * | 2000-07-04 | 2003-02-17 | 노보 노르디스크 에이/에스 | 효소 dpp-iv의 억제제인 헤테로고리 화합물 |
US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
ES2302835T3 (es) | 2001-08-28 | 2008-08-01 | Schering Corporation | Inhibidores de fosfodiesterasa v policiclicos de guanina. |
CA2465893A1 (en) | 2001-11-09 | 2003-05-22 | Schering Corporation | Polycyclic guanine derivative phosphodiesterase v inhibitors |
EP1719772A1 (en) | 2002-05-31 | 2006-11-08 | Schering Corporation | Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof |
EP1521584A1 (en) | 2002-06-17 | 2005-04-13 | Glaxo Group Limited | Purine derivatives as liver x receptor agonists |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
ES2284056T3 (es) * | 2003-07-31 | 2007-11-01 | Schering Corporation | Metabolito de inhibidor de fosfodiesterasa 5 de xantina y sus derivados, utiles para el tratamiento de la disfuncion erectil. |
EP1697363A2 (en) * | 2003-12-16 | 2006-09-06 | Ranbaxy Laboratories Limited | Purine compounds which can be used as phosphodiesterase (pde) type iv inhibitors |
US7501426B2 (en) | 2004-02-18 | 2009-03-10 | Boehringer Ingelheim International Gmbh | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions |
DE102004030502A1 (de) | 2004-06-24 | 2006-01-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel |
DE102004037554A1 (de) | 2004-08-03 | 2006-03-16 | Sanofi-Aventis Deutschland Gmbh | Substituierte 8-Aminoalkylthio-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102004039507A1 (de) * | 2004-08-14 | 2006-03-02 | Sanofi-Aventis Deutschland Gmbh | Substituierte 8-Aminoalkoxi-xanthine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
DE102005035891A1 (de) | 2005-07-30 | 2007-02-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel |
EP1852108A1 (en) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | DPP IV inhibitor formulations |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
CA2810295C (en) | 2006-05-04 | 2017-11-14 | Boehringer Ingelheim International Gmbh | A polymeric form of 1-((4-methyl-quinazolin-2-yl)methyl)-3-7-(2-butyn-1-yl)-8-(3-(r)-aminopiperidin-1-yl)xanthine |
PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
KR20200118243A (ko) | 2008-08-06 | 2020-10-14 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
EP2344195A2 (en) | 2008-09-10 | 2011-07-20 | Boehringer Ingelheim International GmbH | Combination therapy for the treatment of diabetes and related conditions |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
AU2009331471B2 (en) | 2008-12-23 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Salt forms of organic compound |
AR074990A1 (es) | 2009-01-07 | 2011-03-02 | Boehringer Ingelheim Int | Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina |
CA2782179C (en) | 2009-11-27 | 2020-06-23 | Boehringer Ingelheim International Gmbh | Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin |
ES2935300T3 (es) | 2010-05-05 | 2023-03-03 | Boehringer Ingelheim Int | Combiterapia |
ES2953123T3 (es) | 2010-06-24 | 2023-11-08 | Boehringer Ingelheim Int | Terapia para la diabetes |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
EP2731947B1 (en) | 2011-07-15 | 2019-01-16 | Boehringer Ingelheim International GmbH | Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
EP3685839A1 (en) | 2012-05-14 | 2020-07-29 | Boehringer Ingelheim International GmbH | Linagliptin for use in the treatment of albuminuria and kidney related diseases |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
US9526728B2 (en) | 2014-02-28 | 2016-12-27 | Boehringer Ingelheim International Gmbh | Medical use of a DPP-4 inhibitor |
BR112018072401A2 (pt) | 2016-06-10 | 2019-02-19 | Boehringer Ingelheim International Gmbh | combinações de linagliptina e metformina |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT392968B (de) * | 1987-01-30 | 1991-07-25 | Sandoz Ag | Neue xanthinderivate |
GB8826595D0 (en) * | 1988-11-14 | 1988-12-21 | Beecham Wuelfing Gmbh & Co Kg | Active compounds |
GB8906792D0 (en) * | 1989-03-23 | 1989-05-10 | Beecham Wuelfing Gmbh & Co Kg | Treatment and compounds |
GB9020921D0 (en) * | 1990-09-26 | 1990-11-07 | Beecham Group Plc | Novel compounds |
WO1992007852A1 (en) * | 1990-10-25 | 1992-05-14 | G.D. Searle & Co. | Biphenylalkyl xanthine compounds for treatment of cardiovascular disorders |
-
1990
- 1990-09-26 GB GB909020959A patent/GB9020959D0/en active Pending
-
1991
- 1991-09-23 EP EP91917224A patent/EP0550570A1/en not_active Withdrawn
- 1991-09-23 KR KR1019930700919A patent/KR930702351A/ko not_active Application Discontinuation
- 1991-09-23 JP JP3515543A patent/JPH06501251A/ja active Pending
- 1991-09-23 AU AU85413/91A patent/AU653364B2/en not_active Ceased
- 1991-09-23 CA CA002092430A patent/CA2092430A1/en not_active Abandoned
- 1991-09-23 WO PCT/GB1991/001633 patent/WO1992005175A1/en not_active Application Discontinuation
- 1991-09-24 MX MX9101237A patent/MX9101237A/es not_active IP Right Cessation
- 1991-09-24 ZA ZA917610A patent/ZA917610B/xx unknown
- 1991-09-24 NZ NZ239921A patent/NZ239921A/xx unknown
- 1991-09-24 IE IE335091A patent/IE913350A1/en unknown
- 1991-09-25 PT PT99062A patent/PT99062A/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0550570A1 (en) | 1993-07-14 |
AU653364B2 (en) | 1994-09-29 |
WO1992005175A1 (en) | 1992-04-02 |
GB9020959D0 (en) | 1990-11-07 |
ZA917610B (en) | 1992-09-30 |
PT99062A (pt) | 1992-08-31 |
AU8541391A (en) | 1992-04-15 |
CA2092430A1 (en) | 1992-03-27 |
NZ239921A (en) | 1993-12-23 |
KR930702351A (ko) | 1993-09-08 |
IE913350A1 (en) | 1992-04-08 |
JPH06501251A (ja) | 1994-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9101237A (es) | Xantinas substituidas y procedimiento para su preparacion | |
MX24568A (es) | 3-arilcarbonil-1h-indoles y procedimiento para su preparacion. | |
MX174176B (es) | Compuestos azo y procedimiento para su preparacion | |
MX9205279A (es) | Derivados de benzanilida y procedimiento para su preparacion | |
MX9205278A (es) | Derivados de benzanilida y procedimiento para su preparacion | |
MX25829A (es) | Mezclas de polisacaridos sulfatados y procedimiento para su preparacion. | |
MX9101793A (es) | Derivados de tiazolidindiona y procedimiento para su preparacion | |
MX26267A (es) | Aminobenzodiacepinas y procedimiento para su prepaacion. | |
MX9101235A (es) | Xantinas substituidas y procedimiento para su preparacion | |
MX9201780A (es) | Eteres oximicos y procedimiento para su preparacion. | |
MX11155A (es) | Poliamidas y procedimiento para su obtencion | |
MX9205316A (es) | Sulfonilaminocarboniltriazolinonas y procedimiento para su obtencion | |
MX9100845A (es) | Nuevas tienodiazepinas y procedimiento para su preparacion | |
MX9100415A (es) | Piridinas substituidas y procedimiento para su obtencion | |
MX9101516A (es) | Derivados de 1,2,5,6-tetrahidropiridin 3-cetoxima y-3-aldoxina y procedimiento para su preparacion | |
MX21243A (es) | Indenoindoles y procedimiento para su preparacion. | |
MX164079B (es) | 3-aroiloxifenilcarbamatos polimerizables y metodos para su preparacion y uso | |
MX9100811A (es) | Indolonaftiridinas y procedimiento para su preparacion | |
MX9205747A (es) | Pirazolinas y procedimiento para su preparacion. | |
MX7829A (es) | Quinazolindionas y piridopirimindionas y procedimiento para su preparacion | |
MX9205746A (es) | Pirazolinas y procedimiento para su preparacion. | |
MX9102583A (es) | Microgranallas para vidriado y procedimiento para su obtencion. | |
MX9100367A (es) | Derivados de heteroarilcetona y procedimiento para su preparacion | |
MX162953B (es) | Articulo fotosensible y procedimiento para su preparacion | |
MX9101794A (es) | Compuestos de trifendioxazina y procedimiento para su preparacion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration | ||
MM | Annulment or lapse due to non-payment of fees |